(Q30359782)

20 June 2017

1 reference

title

Cell therapy for cardiac repair--lessons from clinical trials. (English)

1 reference

20 June 2017

4

Bernard J Gersh

1 reference

20 June 2017

Atta Behfar

1

1 reference

20 June 2017

Ruben Crespo-Diaz

series ordinal

2

1 reference

20 June 2017

Andre Terzic

series ordinal

3

1 reference

20 June 2017

language of work or name

English

0 references

publication date

4 March 2014

1 reference

Nature Reviews Cardiology

20 June 2017

published in

1 reference

20 June 2017

volume

11

1 reference

20 June 2017

issue

4

1 reference

20 June 2017

page(s)

232-246

1 reference

Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Cost-effectiveness of heart failure therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Digitalis Investigation Group (DIG) trial: a stimulus for further research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Long-term use of a left ventricular assist device for end-stage heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Cell therapy for the treatment of coronary heart disease: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Bone marrow tinctures for cardiovascular disease: lost in translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Genetic enhancement of stem cell engraftment, survival, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Engineered whole organs and complex tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Infrastructure development for human cell therapy translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Bone marrow cells regenerate infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Cell-based therapy for myocardial repair in patients with acute myocardial infarction: Rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Transcoronary transplantation of progenitor cells after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Cell-based therapy of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Pluripotency of mesenchymal stem cells derived from adult marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Intramyocardial, autologous CD34+ cell therapy for refractory angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Cardiopoietry in motion: primed mesenchymal stem cells for ischemic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Report of the American Heart Association (AHA) Scientific Sessions 2012, Los Angeles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Cardiopoietic programming of embryonic stem cells for tumor-free heart repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Stem cell differentiation requires a paracrine pathway in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

The advancing field of cell-based therapy: insights and lessons from clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Stem-cell-based therapy and lessons from the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Organization of myocardial activation during ventricular fibrillation after myocardial infarction: evidence for sustained high-frequency sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Human studies of angiogenic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Importance of the SDF-1:CXCR4 axis in myocardial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Nanowired three-dimensional cardiac patches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Heart repair by reprogramming non-myocytes with cardiac transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Human cardiac stem cell differentiation is regulated by a mircrine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

RETRACTED: Cardiomyogenesis in the aging and failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Evidence for cardiomyocyte renewal in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Optimized delivery system achieves enhanced endomyocardial stem cell retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Potential risks of bone marrow cell transplantation into infarcted hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Tissue engineering of human bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Platelet-rich plasma for managing pain and inflammation in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Cardiopoietic Stem Cell Therapy in Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Stem cell treatment for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Int

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Cardiac bone marrow cell therapy: the proof of the pudding remains in the eating

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

The REPAIR-AMI and ASTAMI trials: cell isolation procedures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

CD34+ autologous human stem cells in treating refractory angina

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Mixed results for bone marrow–derived cell therapy for ischemic heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

SCIPIO brings new momentum to cardiac cell therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Cardiac regeneration: messages from CADUCEUS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Isolation and expansion of adult cardiac stem cells from human and murine heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Endogenous Cardiac Stem Cell Activation by Insulin-Like Growth Factor-1/Hepatocyte Growth Factor Intracoronary Injection Fosters Survival and Regeneration of the Infarcted Pig Heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimul

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Treatment of the ventricular tachycardia with engraftment of pluripotent stem cells-derived cardiomyocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

Replenishing cartilage from endogenous stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.9

What are the costs of heart failure?

31 March 2020

1 reference

12 December 2020

NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE

1 reference

12 December 2020

Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction)

1 reference

12 December 2020

The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: first clinical results.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCARDIO.2014.9

1 reference

20 June 2017

1 reference